Hanjin In is Chairman and CEO of Tae-Chang Industrial Co., Ltd. of South Korea (T-C), an ApiJect partner as well as a leading global manufacturer of needle products and blood bags. Since 2006 he has served as CEO and Chairman for both TCI and its Kovac-Med company, which manufactures specialty precision injection products. Over the past decade, as a Director of a growing number of TCI affiliates from Indonesia to France and Florida, he has also overseen all company operations worldwide.
Established more than 25 years ago as an OEM, T-C today exports to more than 50 nations, including the U.S. and Japan, and serves as an OEM supplier to all major medical suppliers in the region. All of T-C’s products are GMP, ISO and CE certified. In addition to being a manufacturing partner, T-C is a key R&D contributor on the ApiJect Needle Hub component.